Search Results for: "Other News to Note"
-
Other News To Note
Cempra will receive an up-front payment of $10 million and up to $60 million in payments based on the achievement of undisclosed milestones, plus tiered sales royalties following launch of solithromycin in JapanBioWorld Today | Wednesday, May 15, 2013 -
Other News To Note
ZenRx will provide an undisclosed up-front payment, milestones and royalties, and Zenith will commit resources to the Oraxol and Oratecan global development programsBioWorld Today | Tuesday, May 7, 2013 -
Other News To Note
Terms call for Alchemia to receive an undisclosed up-front payment, in addition to the $240 million in preclinical, clinical and commercial launch milestone payments and a single-digit royalty on products that reach the market...Under the terms of the 2011 agreement, Takeda will have global rights to the drugs emerging from the collaboration, and Heptares received a $1.6 million up-front payment and a $4.3 million equity investmentBioWorld International | Wednesday, May 1, 2013 -
Pharma: Other News To Note
Pfizer has received an up-front payment and milestones of $60 million and will be eligible for additional payments associated with the achievement of pre-specified future clinical, regulatory and commercial milestonesBioWorld Today | Tuesday, April 30, 2013 -
Other News To Note
Under the terms, Cara received an undisclosed up-front payment, including an equity investment, and is eligible for further milestone payments tied to clinical and regulatory events in Japan and the U.S., as well as royalties on Japanese sales of any marketed products containing CR845...OBT will receive an undisclosed up-front payment and funding for its activities under the dealBioWorld Today | Tuesday, April 30, 2013 -
Other News To Note
Terms call for Alchemia to receive an undisclosed up-front payment, in addition to the $240 million in preclinical, clinical and commercial launch milestone payments and a single-digit royalty on products that reach the marketBioWorld Today | Wednesday, April 24, 2013 -
Other News To Note
In exchange, FusionVax will pay Advaxis an up-front payment, certain event-based milestones, an annual exclusive licensing fee and annual net sales royaltiesBioWorld Today | Tuesday, April 23, 2013 -
Other News To Note
CSL will receive an exclusive license to the technology for use with an undisclosed target in exchange for an up-front payment, milestone payments and royalties on product salesBioWorld Today | Wednesday, April 17, 2013 -
Other News To Note
to begin a Phase IIa trial of BL-8040, a selective antagonist of chemokine receptor CXCR4, in acute myeloid leukemia (AML...According to the terms, Shasun will be able to use the Debiopharm technology to manufacture synthetic Huperzine-A under GMP quality conditions and commercialize it in pharmaceutical and nutraceutical markets...In other news, GSK experienced manufacturing delays for manufacture and supply of Horizant (gabapentin enacarbil), partnered with XenoPort Inc., of Santa Clara, CalifBioWorld International | Wednesday, April 17, 2013 -
Other News To Note
The objective of the offer is to return to shareholders up to $1 billion of the up-front payment from Weston, Mass.-based Biogen Idec Inc. (See BioWorld Today, Feb. 7, 2013BioWorld Today | Monday, April 15, 2013 -
Other News To Note
Under the framework of the existing 2010 agreement, the new program will entitle Pieris to an up-front payment from Sanofi and committed research funding, as well as payments for the achievement of research, preclinical, regulatory and commercial milestonesBioWorld Today | Thursday, April 11, 2013 -
Other News To Note
Detailed financial terms were not disclosed, but X-BODY will receive an up-front payment, clinical, regulatory and commercial milestones and royaltiesBioWorld Today | Friday, April 5, 2013 -
Other News To Note
Under the terms, BDSI will make an up-front payment of $2 million to Arcion in the form of unregistered shares of BDSI common stockBioWorld Today | Wednesday, March 27, 2013 -
Other News To Note
Under the terms, Theravance granted Clinigen exclusive rights in those territories in exchange for a $5 million up-front payment, plus tiered royalties on net sales of Vibativ ranging from 20 percent to 30 percentBioWorld International | Wednesday, March 13, 2013 -
Other News To Note
Under the terms, Theravance granted Clinigen exclusive rights in those territories in exchange for a $5 million up-front payment, plus tiered royalties on net sales of Vibativ ranging from 20 percent to 30 percentBioWorld Today | Tuesday, March 12, 2013 -
Other News To Note
Under the agreement, Presage will receive an up-front payment, an equity investment and will be eligible for downstream paymentsBioWorld Today | Wednesday, March 6, 2013 -
Other News To Note
Araxes will receive an undisclosed up-front payment as well as R&D funding and will be eligible for milestones and tiered royalties on product salesBioWorld Today | Thursday, February 28, 2013 -
Other News To Note
Lee's will pay Jennerex an undisclosed up-front payment and potential success-based milestonesBioWorld Today | Tuesday, February 26, 2013 -
Other News To Note
Terms of the agreement were not disclosed but include an up-front payment, research funding and success-based milestonesBioWorld Today | Friday, February 22, 2013 -
Other News To Note
The deal called for an up-front payment of $5.9 million, sales milestones of up to $50 million and annual net sales payments tiered up to a double-digit percentage of global net sales, potentially exceeding an aggregate of $300 millionBioWorld Today | Thursday, February 21, 2013
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.